Nanalysis Scientific Corp.
Other OTCCapital Structure
•
in mil. unless spec.Working Capital
•
in mil. unless spec.Growth Rates
•
in mil. unless spec.Quarterly Revenue
•
in mil. unless spec.Quarterly Earnings Per Share
•
in mil. unless spec.Quarterly Dividends Per Share
•
in mil. unless spec.- CEO
- Sean Krakiwsky
- Full Time Employees
- 249
- Sector
- Technology
- Industry
- Hardware, Equipment & Parts
- Address
- Bay 1, 4600 5th Street NE Calgary AB Canada T2E 7C3
- IPO Date
- Apr 16, 2020
- Website
- nanalysis.com
- Similar Companies
- Business
- Nanalysis Scientific Corp. functions as a worldwide innovator in magnetic resonance technology, creating and marketing specialized analytical instruments. The company focuses on compact Nuclear Magnetic Resonance (NMR) spectrometers and advanced Magnetic Resonance Imaging (MRI) systems designed for a broad spectrum of laboratory and industrial uses. These solutions cater to industries such as pharmaceuticals, biotechnology, chemicals, food science, materials research, energy, forensics, and education. The enterprise operates through two principal divisions: Scientific Equipment and Security Services. Its offerings include a suite of NMR platforms, such as the accessible 60 MHz and higher-resolution 100 MHz benchtop units, which have been recognized for their portability, user-friendliness, and reduced maintenance requirements. Nanalysis also provides sophisticated software for both NMR data analysis and MRI applications. Furthermore, the company supplies high-performance electronic components vital for precision scientific instrumentation. Through its Security Services segment, Nanalysis delivers maintenance and installation support for critical security equipment, notably in Canadian airport screening operations. The company distributes its products and services globally through direct sales channels and an established network of partners. Recent strategic initiatives include enhancing its offerings through acquisitions like RS2D for preclinical MRI and high-field NMR consoles, and One Moon Scientific for specialized NMR data processing software. The firm has also forged key partnerships, such as a licensing agreement with IMRIS for MRI components and a collaboration with Wiley for NMR data integration. Headquartered in Calgary, Alberta, Canada, Nanalysis Scientific Corp. continues to emphasize innovation, with new product launches and regulatory certifications further solidifying its market position.
Nanalysis Announces First Quarter 2026 Results
Nanalysis Announces First Quarter 2026 Conference Call
Nanalysis Announces Board Transition and Appointment of Three New Directors
Nanalysis Scientific Corp. (NSCI:CA) Q4 2025 Earnings Call Prepared Remarks Transcript
Nanalysis Announces Fourth Quarter and Full Year 2025 Results
Nanalysis Announces Fourth Quarter and Full Year 2025 Conference Call
Nanalysis Announces Closing of Second Tranche to Complete its $3.4 Million Offering
Nanalysis Announces Upsize to Private Placement and Closing of the First Tranche
Nanalysis Announces $2.5 Million Private Placement
Nanalysis Scientific Corp. (NSCI:CA) Q3 2025 Earnings Call Prepared Remarks Transcript
Nanalysis Announces Third Quarter 2025 Results
Nanalysis Announces Third Quarter 2025 Conference Call
Nanalysis Announces Change of Management
Nanalysis announces support from Wiley for NMR Instruments in KnowItAll 2026
Nanalysis Chosen by IMRIS as Critical Component MRI Supplier
Nanalysis Announces Second Quarter 2025 Conference Call
Nanalysis Announces First Regulated Assay for Pharmaceutical Quality Control via Benchtop NMR Accepted by the United States Pharmacopeia (USP) and European Pharmacopeia (Ph. Euro)
Nanalysis Scientific Corp. (NSCIF) Q1 2025 Earnings Call Transcript
Nanalysis Announces First Quarter 2025 Results
Nanalysis Announces First Quarter 2025 Conference Call